Stephen Mohr
President & CEO
Pharmaceutical
Roivant Sciences
Canada
Biography
Stephen Mohr has over 25 years of experience in pharmaceutical legal and compliance matters. He was previously U.S. General Counsel and Deputy General Counsel, North America at AstraZeneca. Prior to assuming that position, he was Global Compliance Officer for AstraZeneca. He also held a number of senior legal and compliance positions at Bristol-Myers Squibb Company, including Vice President and Senior Counsel, U.S. Medicines. Earlier in his career, he specialized in litigation matters at Weiss David Fross Zelnick & Lehrman, P.C. (now Fross Zelnick Lehrman & Zissu) and Rivkin Leff Sherman & Radler (now Rivkin Radler LLP). Mr. Mohr holds a B.A. from Yale University and a J.D. from the University of Virginia School of Law. Stephen Mohr has over 25 years of experience in pharmaceutical legal and compliance matters. He was previously U.S. General Counsel and Deputy General Counsel, North America at AstraZeneca. Prior to assuming that position, he was Global Compliance Officer for AstraZeneca. He also held a number of senior legal and compliance positions at Bristol-Myers Squibb Company, including Vice President and Senior Counsel, U.S. Medicines. Earlier in his career, he specialized in litigation matters at Weiss David Fross Zelnick & Lehrman, P.C. (now Fross Zelnick Lehrman & Zissu) and Rivkin Leff Sherman & Radler (now Rivkin Radler LLP). Mr. Mohr holds a B.A. from Yale University and a J.D. from the University of Virginia School of Law.
Research Interest
Pharmaceutical Analysis and Quality Assurance Industrial Pharmacy Clinical Pharmacy Pharmaceutical Administration Medicinal Chemistry Drug Discovery and Development